Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000517607 | SCV000614639 | benign | not specified | 2016-11-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001080078 | SCV001012701 | benign | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2023-12-12 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000871097 | SCV001155533 | uncertain significance | not provided | 2017-12-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000871097 | SCV001779535 | likely benign | not provided | 2020-08-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004737593 | SCV005354792 | likely benign | PLEC-related disorder | 2024-06-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |